Astria Therapeutics Grants Stock Options to New Employees
Astria Therapeutics, Inc. (Nasdaq: ATXS) has granted stock options to three new employees under its 2022 Inducement Stock Incentive Plan. The details of the recipients and the specifics of the grant remain private.
The stock options were issued on October 1, 2025, with each option priced at $7.54, reflecting the closing price of Astria's common app on the grant date. The options vest over four years, with a quarter vesting after the first year and the remaining three-quarters vesting monthly over the subsequent 36 months.
Astria granted the options to purchase a total of 173,000 shares of its common app. The company has not publicly disclosed the identities of the employees who received these options.
Astria's stock option grant to new employees, while not publicly disclosing the recipients, aligns with its incentive plan. The options vest gradually, encouraging long-term commitment and performance.
